drugset / Trial / NCT06952998

Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease

NCT06952998

RandomizedParallel-groupSingle-blindTreatment

Summary

This study is a randomized clinical trial that compares the effectiveness of Plasma Rich in Growth Factors (PRGF) with conventional treatment for healing foot ulcers in diabetic patients who also have peripheral arterial disease. The goal is to assess how well PRGF promotes healing over a six-month period.

Timeline

Start
2025-11-01
Primary completion
2026-05-30
Completion
2027-05-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Plasma rich in growth factors Other / unclassified Topical

Indications